MX357828B - Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. - Google Patents
Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación.Info
- Publication number
- MX357828B MX357828B MX2015001677A MX2015001677A MX357828B MX 357828 B MX357828 B MX 357828B MX 2015001677 A MX2015001677 A MX 2015001677A MX 2015001677 A MX2015001677 A MX 2015001677A MX 357828 B MX357828 B MX 357828B
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- growth factors
- composition
- compositions
- neurodegenerative disorders
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000003102 growth factor Substances 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201200810A ES2442242B1 (es) | 2012-08-09 | 2012-08-09 | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |
| PCT/ES2013/000176 WO2014023860A1 (es) | 2012-08-09 | 2013-07-19 | Composición con factores de crecimiento obtenidos a partir del plasma sanguíneo destinada al tratamiento de enfermedades neurodegenerativas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015001677A MX2015001677A (es) | 2015-04-10 |
| MX357828B true MX357828B (es) | 2018-07-25 |
Family
ID=49111229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015001677A MX357828B (es) | 2012-08-09 | 2013-07-19 | Composición con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patología del sistema nervioso central, y su método de fabricación. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20140044795A1 (enExample) |
| EP (1) | EP2883569B1 (enExample) |
| JP (1) | JP6339568B2 (enExample) |
| KR (1) | KR102149162B1 (enExample) |
| CN (1) | CN104519961A (enExample) |
| AR (1) | AR092086A1 (enExample) |
| BR (1) | BR112015002760A2 (enExample) |
| CA (1) | CA2881075A1 (enExample) |
| CL (1) | CL2014003510A1 (enExample) |
| CO (1) | CO7170177A2 (enExample) |
| ES (2) | ES2442242B1 (enExample) |
| IN (1) | IN2014MN02675A (enExample) |
| MX (1) | MX357828B (enExample) |
| PE (1) | PE20150616A1 (enExample) |
| RU (1) | RU2696497C2 (enExample) |
| TW (1) | TWI649084B (enExample) |
| WO (1) | WO2014023860A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2016003282A1 (es) | 2016-12-21 | 2017-08-18 | Univ Chile | Virus aav/igf2, método de tratamiento genético y su uso en enfermedades relacionadas con mal plegamiento de proteínas tal como la enfermedad de huntington |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1137401B1 (en) * | 1998-12-09 | 2005-11-23 | Chiron Corporation | Administration of neurotrophic agents to the central nervous system |
| AR022333A1 (es) | 1999-01-26 | 2002-09-04 | Anitua Aldecoa Eduardo | Regenerador de tejido oseo |
| US6811777B2 (en) * | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
| US7608258B2 (en) * | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
| ES2221770B2 (es) | 2002-04-19 | 2006-07-16 | Eduardo Anitua Aldecoa | Metodo de preparacion de un compuesto para la regeneracion de tejidos. |
| US20060004189A1 (en) * | 2004-07-02 | 2006-01-05 | James Gandy | Compositions for treating wounds and processes for their preparation |
| AU2006282799B2 (en) * | 2005-08-26 | 2012-11-29 | Healthpartners Research & Education | Methods for treatment of headaches by administration of oxytocin |
| US9808509B2 (en) * | 2007-06-08 | 2017-11-07 | Healthpartners Research Foundation | Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system |
| ES2333498B1 (es) * | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
| AU2008297889A1 (en) * | 2007-09-14 | 2009-03-19 | Formycon Ag | Use of SLIT, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| PL2430977T3 (pl) | 2009-05-14 | 2020-08-24 | Biotechnology Institute, I Mas D, S.L. | Sposób preparowania co najmniej jednego związku z krwi i urządzenie do pobierania próbek do stosowania podczas realizacji wspomnianego sposobu |
| KR101114712B1 (ko) * | 2009-10-23 | 2012-02-29 | 세원셀론텍(주) | 염화칼슘용액과 제1형 콜라겐으로 혈소판풍부혈장(ｐｒｐ)을 활성화하여 조직재생을 유도하는 조성물의 제조방법 |
| ES2369945B1 (es) | 2011-07-29 | 2012-10-15 | Eduardo Anitua Aldecoa | Procedimiento de obtención de una composición que contiene factores de crecimiento a partir de un compuesto sanguíneo, y composición obtenible por dicho procedimiento. |
-
2012
- 2012-08-09 ES ES201200810A patent/ES2442242B1/es not_active Expired - Fee Related
-
2013
- 2013-07-19 JP JP2015525915A patent/JP6339568B2/ja not_active Expired - Fee Related
- 2013-07-19 ES ES13756518.0T patent/ES2662385T3/es active Active
- 2013-07-19 MX MX2015001677A patent/MX357828B/es active IP Right Grant
- 2013-07-19 TW TW102125858A patent/TWI649084B/zh not_active IP Right Cessation
- 2013-07-19 KR KR1020157001551A patent/KR102149162B1/ko not_active Expired - Fee Related
- 2013-07-19 RU RU2015104076A patent/RU2696497C2/ru active
- 2013-07-19 CN CN201380041280.4A patent/CN104519961A/zh active Pending
- 2013-07-19 WO PCT/ES2013/000176 patent/WO2014023860A1/es not_active Ceased
- 2013-07-19 CA CA2881075A patent/CA2881075A1/en not_active Abandoned
- 2013-07-19 BR BR112015002760A patent/BR112015002760A2/pt not_active Application Discontinuation
- 2013-07-19 PE PE2015000116A patent/PE20150616A1/es not_active Application Discontinuation
- 2013-07-19 EP EP13756518.0A patent/EP2883569B1/en not_active Not-in-force
- 2013-08-08 AR ARP130102835A patent/AR092086A1/es unknown
- 2013-08-08 US US13/962,340 patent/US20140044795A1/en not_active Abandoned
-
2014
- 2014-12-23 CL CL2014003510A patent/CL2014003510A1/es unknown
- 2014-12-31 IN IN2675MUN2014 patent/IN2014MN02675A/en unknown
-
2015
- 2015-01-20 CO CO15010369A patent/CO7170177A2/es unknown
-
2016
- 2016-03-08 US US15/063,969 patent/US20160184360A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2442242A1 (es) | 2014-02-10 |
| AR092086A1 (es) | 2015-03-25 |
| KR20150040860A (ko) | 2015-04-15 |
| MX2015001677A (es) | 2015-04-10 |
| CL2014003510A1 (es) | 2015-05-04 |
| KR102149162B1 (ko) | 2020-08-31 |
| EP2883569A1 (en) | 2015-06-17 |
| ES2662385T3 (es) | 2018-04-06 |
| TW201408310A (zh) | 2014-03-01 |
| EP2883569B1 (en) | 2017-12-20 |
| US20160184360A1 (en) | 2016-06-30 |
| RU2015104076A (ru) | 2016-09-27 |
| CA2881075A1 (en) | 2014-02-13 |
| CN104519961A (zh) | 2015-04-15 |
| TWI649084B (zh) | 2019-02-01 |
| US20140044795A1 (en) | 2014-02-13 |
| IN2014MN02675A (enExample) | 2015-08-28 |
| RU2696497C2 (ru) | 2019-08-02 |
| JP6339568B2 (ja) | 2018-06-06 |
| WO2014023860A1 (es) | 2014-02-13 |
| ES2442242B1 (es) | 2014-11-25 |
| PE20150616A1 (es) | 2015-05-25 |
| CO7170177A2 (es) | 2015-01-28 |
| BR112015002760A2 (pt) | 2020-04-22 |
| JP2015524464A (ja) | 2015-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3180009A4 (en) | Zoledronic acid dosage forms for the treatment of pain | |
| IL270752B (en) | Pyrrolopyridine-aniline compounds for the treatment of skin disorders | |
| EP3122878A4 (en) | Mrna therapy for the treatment of ocular diseases | |
| PH12013502240B1 (en) | Novel compounds as modulators of protein kinase | |
| IN2014DN00288A (enExample) | ||
| IN2014DN00286A (enExample) | ||
| IN2014MN00093A (enExample) | ||
| IN2014MN01378A (enExample) | ||
| IN2014DN06792A (enExample) | ||
| MX2022009155A (es) | Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh). | |
| EP4591936A3 (en) | Treatment of respiratory diseases | |
| PH12016500140A1 (en) | Heterobicycloaryl rorc2 inhibitors and methods of use thereof | |
| IL258032A (en) | Compounds and preparations for the treatment of ocular disorders | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| IL282643A (en) | Soft combinations for the treatment of hematological diseases | |
| EA201691567A1 (ru) | Способы лечения легких травм головного мозга | |
| MX395492B (es) | Usos terapeuticos de l-4 cloroquinurenina. | |
| ES3049333T3 (en) | Compounds for the treatment of respiratory diseases | |
| EP2855438A4 (en) | Novel compounds and compositions for the treatment of respiratory disorders or diseases | |
| MX2015001677A (es) | Composicion con factores de crecimiento destinada al tratamiento intranasal de una enfermedad neurodegenerativa u otra patologia del sistema nervioso central, y su metodo de fabricacion. | |
| EP3226883C0 (en) | COMPOSITIONS FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA | |
| EP3284475A4 (en) | Agent for prevention or treatment of corneal disorders | |
| GB201604359D0 (en) | Treatment of tissue disorders | |
| GB2553686A8 (en) | Ethynylxanthines, preparation and use as calcium ion channel modulators | |
| HK40026704A (en) | Pyrrolopyridine-aniline compounds for treatment of dermal disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |